Muramidase (Lysozyme)

Subscribe to Selected New Research on Muramidase

2377 relevant articles (76 outcomes, 203 trials/studies) found for this Bio-Agent

Description: A basic enzyme that is present in saliva, tears, egg white, and many animal fluids. It functions as an antibacterial agent. The enzyme catalyzes the hydrolysis of 1,4-beta-linkages between N-acetylmuramic acid and N-acetyl-D-glucosamine residues in peptidoglycan and between N-acetyl-D-glucosamine residues in chitodextrin. EC 3.2.1.17.

Also Known As:

Lysozyme; Leftose; N-Acetylmuramide Glycanhydrolase; Glycanhydrolase, N-Acetylmuramide; N Acetylmuramide Glycanhydrolase; Peptidoglycan N-acetylmuramoylhydrolase

Relationship Network

Bio-Agent Context: Research Results

Enzymes and Coenzymes: 1

Enzymes: 25587

Hydrolases: 580

Glycoside Hydrolases: 228

hen egg lysozyme peptide (46-61): 1

iron lysozyme glutarate: 1

mouse lysozyme M: 1

PABRON-GOLD: 1

alpha-O-methyl N-glycylglucosaminide lysozyme

chlamysin

CPL7 lysozyme

endo-beta-1,4-N-acetylmuramylhydrolase

Enterobacteria phage PRD1 P15 protein

glycine methyl ester lysozyme

hen egg lysozyme (105-115)

hen egg lysozyme (48-62)

hen egg lysozyme peptide (115-129)

hen egg lysozyme peptide (18-33)

hen egg lysozyme peptide (31-47)

hen egg lysozyme peptide (48-61)

hen egg lysozyme peptide (50-62)

hen egg lysozyme peptide (52-61)

hen egg lysozyme peptide (85-96)

kynurenine 62-lysozyme

Lacrozym

Lactococcus lactis AcmA protein

Lactococcus lactis LysI protein

lysozyme-glucose stearic acid monoester

monomethoxypolyethylene glycol--conjugated hen lysozyme

mouse lysozyme P

N,O-diacetylmuramidase

N-succinyl lysozyme

oxindoleamine-62 lysozyme

Streptococcus thermophilus Mur1 protein

T4 lysozyme (11-36)

T4 lysozyme (38-51)

zebrafish lysozyme protein

Experts

1.	Light, R Bruce: 7 articles (06/2008 - 03/2003)
2.	Mink, Steven N: 7 articles (06/2008 - 03/2003)
3.	Jacobs, Hans: 7 articles (06/2008 - 03/2003)
4.	Cheng, Zhao-Qin: 6 articles (06/2008 - 01/2004)
5.	Hung, Chen-Road: 4 articles (12/2007 - 09/2002)
6.	Grateau, Gilles: 4 articles (01/2006 - 03/2002)
7.	Valleix, Sophie: 4 articles (01/2006 - 03/2002)
8.	Bose, Deepak: 4 articles (10/2005 - 03/2003)
9.	Duke, Krika: 4 articles (10/2005 - 03/2003)
10.	Kasian, Krika: 3 articles (06/2008 - 11/2007)

Related Diseases

1.	Infection 07/01/1992 - "One of the important non-specific defensive factors of the organism participating in the protection against infections is lysozyme. " 07/07/2000 - "The pgdA gene may contribute to pneumococcal virulence by providing protection against host lysozyme, which is known to accumulate in high concentrations at infection sites." 09/01/2002 - "Since lysozyme is the only known pulmonary enzyme that can lyse bacterial cell wall PGN, other innate immune molecules appear to be responsible for signalling and enhancing the clearance of GPB infection from the lung. " 09/01/1981 - "In all patients, lysozyme returned to normal when the infection cleared. " 02/15/2004 - "In survival studies, no lysozyme M(-/-) mice survived beyond 72 hours after infection, whereas 75% of lysozyme(tg) (p < 0.01) and 25% of WT mice survived to 120 hours (p < 0.01). " Order ALL the reference details at left...
2.	Carcinoma (Carcinomatosis) 07/01/1982 - "Lysozyme in human gastric carcinoma: a retrospective immunohistochemical study." 11/01/2003 - "Recently, it was demonstrated that patients having lysozyme-secreting breast carcinomas were associated with a favorable prognosis. " 09/01/2001 - "Lysozyme expression by breast carcinomas, correlation with clinicopathologic parameters, and prognostic significance." 01/01/2000 - "Lysozyme and protein were also measured in the biological fluids derived from human bronchial preparations obtained from patients who had undergone surgery for lung carcinoma. " 11/01/1996 - "Stimulation of GALT and activation of mesenteric lymph node lymphocytes by a modified lysozyme in CBA mice with MCa mammary carcinoma." Order ALL the reference details at left...
3.	Neoplasms (Cancer) 01/01/2008 - "Immunohistochemical studies show the tumor cells to be positive for CD45 (LCA), CD45RO, CD4, CD68, and lysozyme; and negative for all other T-, B-, macrophage, follicular dendritic- and hematopoietic-cell markers. " 01/01/2008 - "Taken together, our studies clearly show that the newly identified marine lysozyme is a potent antitumor molecule, which may inhibit tumor growth and inhibit angiogenesis. " 10/01/2000 - "This study was undertaken for determination of lysozyme concentration in urine of 32 oesophageal cancer patients to evaluate if this enzyme activity changes in oesophageal cancer used for detection of this cancer especially in its early stage. " 09/01/2000 - "A panel of immunohistochemical studies revealed that the majority of tumors were immunoreactive for at least two markers of vascular differentiation (CD34, FVIIIRAg, VEGFR3, and CD31) and at least one marker of histiocytic differentiation (CD68 and/or lysozyme). " 02/01/1998 - "The purpose of this study was to discuss the anti-tumor function of lysozyme (LZM) to laryngocarcinoma. " Order ALL the reference details at left...
4.	Pneumonia (Pneumonitis) 01/01/2002 - "Our clinic-laboratory studies have revealed a sharp deficit of endogenic lysozyme in the blood serum of leukemic patients and extremely low lysozyme content in lavage liquid, from leukemic patients, with pneumonia. " 01/01/2001 - "Correspondingly, the values of neutrophilic infiltration, macrophageal phagocytic and microbicidal activities and the levels of lysozyme and sIg-A may be serve as markers of the lingering course of acute pneumonias." 01/01/1991 - "[The dynamic lysozyme activity of the bronchial secretion in children in the acute period of pneumonia]" 01/01/1988 - "[Lysozyme content in biological substrates and immunological indices of the blood in pneumonia patients]" 11/01/1978 - "[Lysozyme in pneumonia in infants]" Order ALL the reference details at left...
5.	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 03/01/1978 - "Mean faecal lysozyme levels, expressed either as a concentration or as total daily excretion, in patients with inflammatory bowel disease are very significantly greater than values in healthy controls and in diseased subjects without diarrhoea but are not significantly different from those subjects with other causes of diarrhoea." 03/01/1998 - "This study was undertaken to determine whether measurement of fecal lysozyme is helpful in determining disease activity in inflammatory bowel disease. " 04/01/1978 - "This study indicates that measurement of the level of serum lysozyme in individual patients is not helpful in determining the cause or degree of activity of nonspecific inflammatory bowel disease." 04/01/2002 - "The aim of this study was to investigate the expression of HNP 1-3 and lysozyme in normal and active inflammatory bowel disease (IBD) mucosa. " 03/01/1998 - "Fecal lysozyme in assessment of disease activity in inflammatory bowel disease." Order ALL the reference details at left...

Related Drugs and Biologics

1.	Lactoferrin
2.	Glucuronidase
3.	Proteins (Proteins, Gene)
4.	Enzymes
5.	Peroxidase (Myeloperoxidase)
6.	Complement System Proteins (Complement)
7.	Anti-Bacterial Agents (Antibiotics)
8.	Immunoglobulin A (IgA)
9.	Immunoglobulins (Immunoglobulin)
10.	Antibodies

Related Therapies and Procedures

1.	Oral Administration
2.	Microspheres (Microsphere)
3.	Laser Therapy (Surgery, Laser)
4.	Fluid Therapy (Oral Rehydration Therapy)
5.	Anesthesia

Best Treatments:
Research Summary Report
on Infection

CureHunter Patient-Physician Summary Reports collect in one document all the medications ever reported in the US National Library of Medicine—1949 to the present—to be effective against your target disease. CureHunter research summary reports will vary in length from 25 to 250 pages. Analytic charts allow you and your physicians to see at a glance your medication options—including new, promising, off-label and experimental all rated for clinical efficacy.

Free Updates for 1 Year
All 14726 Outcomes
Top 200 Key Drugs and Biologics
Top 50 Key Therapies and Procedures
Detailed History Charts
Full Research Reference Details
Sample PDF Report on Psoriasis >>

Price:

$24.00 & Delivery via PDF download
updates for 1 year

Research Interface

Rapidly retrieve summaries of all the evidence for any disease in seconds. Save hours of search and analysis time. CureHunter is unlike any "search engine" you have ever used. Where standard "search engines" produce lists of links, CureHunter quantifies evidence, extracts it from the literature and calculates a result you can use to immediately facilitate evidence based decision making in Real Clinical Time.

Unlimited Disease, Drug and Therapy Search
2 clicks from Disease to Drug to Evidence
Trial References
All the Positive Outcomes
Detailed Relationship Timeline Charts
Full Article Reference Details
Includes Mobile Interface Subscription
One-click to FDA Products/Patents
Request Institution License Details >>

Price:

$490.00 access via web interface
1 year subscription

Proceed to Checkout >>

Mobile Interface

Retrieve summaries of all the evidence for any disease from your Mobile Phone or PDA. Accelerate decision making in the field. Speed up your study of new drug and disease domains. Refresh your knowledge on the road.

Access from any web enabled PDA or Phone
Trial references
All the Positive Outcomes
Drug and Therapy searches
Full Article Reference Details
Try Mobile Interface >>

Price:

$45.00 access via "curehunter.com/m"
1 year subscription

Proceed to Checkout >>